Cite
Ascertaining the Utility of the Glycemia Risk Index for Glucose Outcomes With Hybrid Closed-Loop Therapy in Adolescents and Adults With Type 1 Diabetes.
MLA
Thivolet, Charles, et al. “Ascertaining the Utility of the Glycemia Risk Index for Glucose Outcomes With Hybrid Closed-Loop Therapy in Adolescents and Adults With Type 1 Diabetes.” Journal of Diabetes Science & Technology, vol. 18, no. 5, Sept. 2024, pp. 1251–52. EBSCOhost, https://doi.org/10.1177/19322968241258742.
APA
Thivolet, C., Lebbar, M., Perge, K., Nicolino, M., & Villar-Fimbel, S. (2024). Ascertaining the Utility of the Glycemia Risk Index for Glucose Outcomes With Hybrid Closed-Loop Therapy in Adolescents and Adults With Type 1 Diabetes. Journal of Diabetes Science & Technology, 18(5), 1251–1252. https://doi.org/10.1177/19322968241258742
Chicago
Thivolet, Charles, Maha Lebbar, Kevin Perge, Marc Nicolino, and Sylvie Villar-Fimbel. 2024. “Ascertaining the Utility of the Glycemia Risk Index for Glucose Outcomes With Hybrid Closed-Loop Therapy in Adolescents and Adults With Type 1 Diabetes.” Journal of Diabetes Science & Technology 18 (5): 1251–52. doi:10.1177/19322968241258742.